povidone-iodine has been researched along with Pemphigus* in 2 studies
1 trial(s) available for povidone-iodine and Pemphigus
Article | Year |
---|---|
A preliminary clinical trial comparing wet silver dressings versus wet-to-dry povidone-iodine dressings for wound healing in pemphigus vulgaris patients.
There is insufficient evidence concerning the efficacy of wet silver-containing dressings for wound healing in pemphigus vulgaris (PV). In this randomized, controlled clinical trial, 58 patients with PV skin erosions (10%-70% body surface area) were assigned to receive either wet silver-containing dressings (n = 28) or wet to dry povidone-iodine dressings as a control (n = 30). The patients in the treatment group demonstrated a significant improvement in the number of dressing changes, wound healing time, and duration of hospital stay compared with the control group. Patients treated with wet silver dressings had significantly lower NRS pain scores and reported better subjective satisfaction compared with the control group. The only adverse reactions were an occasional abnormal discharge or infection, but there was no difference between the two groups. In our study the wet silver-containing dressings were safe and effective for the treatment of wound healing in PV patients. Topics: Bandages; Humans; Pemphigus; Povidone-Iodine; Silver; Wound Healing | 2021 |
1 other study(ies) available for povidone-iodine and Pemphigus
Article | Year |
---|---|
Tufted hair folliculitis associated with pemphigus vulgaris.
Tufted hair folliculitis (THF) is a rare disease which is characterized by the emergence of multiple hairs from widely dilated follicular orifices surrounded by an inflammatory infiltrate resulting in scarring alopecia. The pathogenesis is not yet fully understood. Although colonization with Staphylococcus aureus could not always be detected and systemic treatment with antibiotics alone is not sufficient, this microorganism is considered to play an important role. Around 30 patients with THF have been reported since the first publication. We present a patient with pemphigus vulgaris who developed THF. To our knowledge, this is the fourth case with an association of these two entities. Amongst other causing mechanisms, the autoimmune reaction may play an important role for the development of THF. Topics: Administration, Topical; Alopecia; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Dermatologic Agents; Drug Therapy, Combination; Folliculitis; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pemphigus; Povidone-Iodine; Staphylococcal Skin Infections; Staphylococcus aureus | 2003 |